Cost-Effectiveness of ApoB, Non-HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy. - Luebbe S; Sniderman AD; Moran AE; Wilkins JT; Kohli-Lynch CN (JAMA, 2026)